Amendment: Marketing authorisations for human & veterinary medicines

This procedure updates the rules for how variations—or changes—to the terms of marketing authorisations for human and veterinary medicines are examined. It aims to streamline the process of updating product information and safety data to ensure medicines remain safe and effective on the market.

Pharmaceutical companies and veterinary medicine providers are affected. They will face updated requirements when requesting changes to their existing product licenses.